Drug recall · May 14, 2025
Clindamycin HCl Capsule recall
Why: CGMP Deviations - products manufactured in a shared facility with Ezetimibe tablets.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC#: 70518-3772-02
- Lots / codes
Lot#: B3698036-033125, B3688703-032625, Exp.: 07/31/2026.
- Quantity
- 23 bottles/30 count- 690 capsules
- Company
- RemedyRePack Inc., Indiana, PA
- Distribution
- Within U.S - PA, VA, FL.
- Initiated
- April 22, 2025 · Voluntary: Firm initiated
- Classified
- May 6, 2025
- Reported
- May 14, 2025
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Clindamycin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.